ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #1,505Top JournalHybrid

Oncologist

Acronym:to
•
Abbreviation (ISO):ONCOLOGIST
•
Identifier (ISSN):1083-7159(Print)/1549-490X(Online)
•
Publisher:AlphaMed Press
Clarivate IF (2026)
4.7↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Oncologist

WoS Q2
24685.3120185.2520195.0320205.8420225.820234.820244.220254.72026
Annual Impact Factor Metric
Current (2026):4.7
Scopus SJR & RankScopus Q1
1.96
#1,505

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
204

204 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate4.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
278articles/year
99.8% Gold OA•86.28% Original Research

Aims & Scope

The Oncologist® is dedicated to translating the latest research developments into the best multidimensional care for cancer patients. Thus, The Oncologist is committed to helping physicians excel in this ever-expanding environment through the publication of timely reviews, original studies, and commentaries on important developments. We believe that the practice of oncology requires both an understanding of a range of disciplines encompassing basic science related to cancer, translational research, and clinical practice, but also the socioeconomic and psychosocial factors that determine access to care and quality of life and function following cancer treatment.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineGeneticsOncology & Cancer ResearchPathologyOncologySurgeryChemistryBiochemistryBioinformaticsImmunologyMathematicsPsychology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q2
Rank97/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank102/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.7
Articles / Year560
Total Citations150
2025
IF4.2
Articles / Year575
Total Citations1,497
2024
IF4.8
Articles / Year418
Total Citations3,359
2023
IF5.8
Articles / Year377
Total Citations4,670
2022
IF5.837
Articles / Year339
Total Citations6,385

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,505Scopus Q1SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.96

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.64

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,780 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,332
3-Year Documents900
Citable Documents830

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate46.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
Medicine (miscellaneous)Q1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Oncologist (acronym: to, abbr: ONCOLOGIST, ISSN: 1083-7159) is a peer-reviewed international scholarly journal in the field of Medicine, published by AlphaMed Press in United States since 1996. The periodical holds a Journal Impact Factor (JIF) of 4.70, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.960 (Q1), an H-index of 204.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 278 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,780 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
AlphaMed Press
Publication Language
English
Frequency
Monthly
Founding Year
1996
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ALPHAMED PRESS, 318 BLACKWELL ST, STE 260, DURHAM, USA, NC, 27701-2884

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 1894f72e-bac0-46c5-b6d1-f13c0a909363
Database Updated: 2026-09-28